Showing results (21-30 of 3,193) with videos related to
Sort By:
Pageof 320
Experimental Neurology|August 26, 1998
Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeysE F Domino, L NiReviews in Clinical & Basic Pharmacology|July 1, 1987
Synaptic pharmacology of the hippocampusR Pohorecki, E F DominoJournal of Clinical Psychopharmacology|October 1, 1982
A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TDB Kovacic, E F DominoClinical Pharmacology and Therapeutics|June 19, 1998
Effects of tobacco smoking and abstinence on middle latency auditory evoked potentialsT Kishimoto, E F DominoArchives Internationales De Pharmacodynamie Et De Therapie|October 1, 1982
Temporal variations in the effect of morphine and nalorphine on total brain acetylcholine content in the ratG Labrecque, E F DominoThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeysE F Domino, J ShengPsychopharmacology|January 1, 1984
Fluphenazine-induced acute and tardive dyskinesias in monkeysB Kovacic, E F DominoThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeysE F Domino, J ShengThe Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeysE F Domino, L NiResearch Communications in Chemical Pathology and Pharmacology|February 1, 1977
In vitro studies of some chlorpromazine metabolites as potential N-methyltransferase inhibitorsS Sangiah, E F DominoPageof 320